DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1.

BMC Cancer · 2012 · PMC3462721 · PMID 22583667

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

showed a trendp = 0.11not close (p > 0.1)

The high DcR3 group also showed a trend towards worse overall survival by ten months ( p = 0.11, Figure 1 D).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.